scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1042374032 |
P356 | DOI | 10.1038/497443A |
P698 | PubMed publication ID | 23698439 |
P50 | author | Felix Rey | Q20434957 |
P2860 | cites work | The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry | Q24620686 |
The global distribution and burden of dengue | Q24628768 | ||
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion | Q24736810 | ||
Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification | Q27315772 | ||
Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes | Q27477610 | ||
Crystal Structure of the West Nile Virus Envelope Glycoprotein | Q27477648 | ||
A ligand-binding pocket in the dengue virus envelope glycoprotein | Q27477685 | ||
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus | Q27642288 | ||
Cryo-EM structure of the mature dengue virus at 3.5-Å resolution | Q27675507 | ||
Dengue structure differs at the temperatures of its human and mosquito hosts | Q27677270 | ||
Structural Changes in Dengue Virus When Exposed to a Temperature of 37 C | Q27677962 | ||
Cross-reacting antibodies enhance dengue virus infection in humans | Q28281588 | ||
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial | Q29616259 | ||
Conformational changes of the flavivirus E glycoprotein | Q29618170 | ||
Neutralization and antibody-dependent enhancement of dengue viruses | Q29618172 | ||
Structure of West Nile Virus | Q29618173 | ||
Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials | Q34431491 | ||
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions | Q35982791 | ||
Dengue: The Continual Re-Emergence of a Centuries-Old Disease | Q40255716 | ||
P433 | issue | 7450 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Dengue virus | Q476209 |
P304 | page(s) | 443-444 | |
P577 | publication date | 2013-05-01 | |
P1433 | published in | Nature | Q180445 |
P1476 | title | Dengue virus: two hosts, two structures | |
P478 | volume | 497 |
Q38860632 | A novel mosquito ubiquitin targets viral envelope protein for degradation and reduces virion production during dengue virus infection |
Q34261496 | Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition |
Q96292850 | Computational modelling of flavivirus dynamics: the ins and outs |
Q42988467 | Dengue Virus and Blood Transfusion |
Q92939082 | Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model |
Q45324483 | Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. |
Q40159006 | Identification of sequence motifs involved in Dengue virus-host interactions |
Q38990899 | Increasing Complexity of Vaccine Development |
Q26314441 | Infection Rates by Dengue Virus in Mosquitoes and the Influence of Temperature May Be Related to Different Endemicity Patterns in Three Colombian Cities |
Q40189080 | Interaction of Flaviviruses with Reproduction Inhibitors Binding in β-OG Pocket: Insights from Molecular Dynamics Simulations |
Q26314452 | Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control |
Q28804225 | The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis |
Q34594111 | Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination |
Search more.